<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font23 { font-size : 23; } .font25 { font-size : 25; } .font27 { font-size : 27; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">patients </span>
   <span class="font27">COVID- </span>
   <span class="font25">treatment </span>
   <span class="font23">SARS-CoV- </span>
   <span class="font23">coronavirus </span>
   <span class="font23">viral </span>
   <span class="font21">respiratory </span>
   <span class="font20">infection </span>
   <span class="font20">clinical </span>
   <span class="font20">efficacy </span>
   <span class="font20">remdesivir </span>
   <span class="font19">{border-style </span>
   <span class="font18">px;} </span>
   <span class="font18">virus </span>
   <span class="font18">#ffffff;} </span>
   <span class="font18">severe </span>
   <span class="font17">disease </span>
   <span class="font17">potential </span>
   <span class="font17">day </span>
   <span class="font17">shown </span>
   <span class="font16">Mar </span>
   <span class="font16">antiviral </span>
   <span class="font15">SARS-CoV </span>
   <span class="font15">acute </span>
   <span class="font15">hydroxychloroquine </span>
   <span class="font15">syndrome </span>
   <span class="font15">RNA </span>
   <span class="font14">MERS-CoV </span>
   <span class="font14">Med </span>
   <span class="font14">activity </span>
   <span class="font14">human </span>
   <span class="font14">novel </span>
   <span class="font14">Ebola </span>
   <span class="font14">Infect </span>
   <span class="font14">agents </span>
   <span class="font14">favipiravir </span>
   <span class="font14">inhibitor </span>
   <span class="font14">inhibitors </span>
   <span class="font14">plasma </span>
   <span class="font14">promising </span>
   <span class="font14">protease </span>
   <span class="font14">therapy </span>
   <span class="font13">Chinese </span>
   <span class="font13">Microbiol </span>
   <span class="font13">azithromycin </span>
   <span class="font13">critically </span>
   <span class="font13">days </span>
   <span class="font13">drug </span>
   <span class="font13">ill </span>
   <span class="font13">influenza </span>
   <span class="font13">patients. </span>
   <span class="font13">px; </span>
   <span class="font13">therapeutic </span>
   <span class="font13">vitro </span>
   <span class="font13">{font-family </span>
   <span class="font13">Feb </span>
   <span class="font13">However, </span>
   <span class="font13">Immunol </span>
   <span class="font13">SARS </span>
   <span class="font13">cells </span>
   <span class="font13">chloroquine </span>
   <span class="font13">combination </span>
   <span class="font13">drugs </span>
   <span class="font13">font-size </span>
   <span class="font13">host </span>
   <span class="font13">including </span>
   <span class="font13">observed </span>
   <span class="font13">polymerase </span>
   <span class="font13">used </span>
   <span class="font12">ACE </span>
   <span class="font12">Dis </span>
   <span class="font12">Inhibition </span>
   <span class="font12">LPV/RTV </span>
   <span class="font12">Wuhan, </span>
   <span class="font12">active </span>
   <span class="font12">antibodies </span>
   <span class="font12">antibody </span>
   <span class="font12">cases </span>
   <span class="font12">cathepsin </span>
   <span class="font12">double; </span>
   <span class="font12">early </span>
   <span class="font12">effective </span>
   <span class="font12">infection. </span>
   <span class="font12">inhibit </span>
   <span class="font12">load </span>
   <span class="font12">lower </span>
   <span class="font12">model </span>
   <span class="font12">outbreak </span>
   <span class="font12">plus </span>
   <span class="font12">pneumonia </span>
   <span class="font12">polyclonal </span>
   <span class="font12">prevention </span>
   <span class="font12">protein </span>
   <span class="font12">reported </span>
   <span class="font12">use </span>
   <span class="font12">(COVID-) </span>
   <span class="font12">Additionally, </span>
   <span class="font12">Elsevier </span>
   <span class="font12">Engl </span>
   <span class="font12">Taiwan </span>
   <span class="font12">administered </span>
   <span class="font12">anti-SARS-CoV- </span>
   <span class="font12">border-color </span>
   <span class="font12">border-width </span>
   <span class="font12">cell </span>
   <span class="font12">convalescent </span>
   <span class="font12">daily </span>
   <span class="font12">distress </span>
   <span class="font12">endosomal </span>
   <span class="font12">evidence </span>
   <span class="font12">high </span>
   <span class="font12">important </span>
   <span class="font12">inhibits </span>
   <span class="font12">research </span>
   <span class="font12">rhesus </span>
   <span class="font12">solid; </span>
   <span class="font12">spike </span>
   <span class="font12">studyLancet </span>
   <span class="font12">target </span>
   <span class="font12">teicoplanin </span>
   <span class="font12">tract </span>
   <span class="font12">treating </span>
   <span class="font12">twice </span>
   <span class="font12">viruses </span>
   <span class="font12">{font-style </span>
   <span class="font12">{font-weight </span>
   <span class="font11">(e.g., </span>
   <span class="font11">Agents </span>
   <span class="font11">COVID-. </span>
   <span class="font11">COVID-: </span>
   <span class="font11">Care </span>
   <span class="font11">China </span>
   <span class="font11">China: </span>
   <span class="font11">Despite </span>
   <span class="font11">RNA-dependent </span>
   <span class="font11">Remdesivir </span>
   <span class="font11">Res </span>
   <span class="font11">addition, </span>
   <span class="font11">administration </span>
   <span class="font11">adults </span>
   <span class="font11">ahead </span>
   <span class="font11">alternative </span>
   <span class="font11">anti-inflammatory </span>
   <span class="font11">associated </span>
   <span class="font11">bold </span>
   <span class="font11">caused </span>
   <span class="font11">centre </span>
   <span class="font11">children </span>
   <span class="font11">concentration </span>
   <span class="font11">control </span>
   <span class="font11">courier; </span>
   <span class="font11">demonstrated </span>
   <span class="font11">effect </span>
   <span class="font11">em; </span>
   <span class="font11">entry </span>
   <span class="font11">enzyme </span>
   <span class="font11">followed </span>
   <span class="font11">good </span>
   <span class="font11">late </span>
   <span class="font11">monoclonal </span>
   <span class="font11">mouse </span>
   <span class="font11">note, </span>
   <span class="font11">potency </span>
   <span class="font11">print] </span>
   <span class="font11">progression </span>
   <span class="font11">prophylactic </span>
   <span class="font11">pt;} </span>
   <span class="font11">receptor </span>
   <span class="font11">regimen </span>
   <span class="font11">resource </span>
   <span class="font11">ribavirin </span>
   <span class="font11">safety </span>
   <span class="font11">studies </span>
   <span class="font11">suggested </span>
   <span class="font11">targets </span>
   <span class="font11">tissue </span>
   <span class="font11">trial </span>
   <span class="font11">viruses. </span>
   <span class="font11">zoonotic </span>
  </p>
 </body>
</html>
